MOMA Therapeutics operates as a biotechnology company.
MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 10, 2022 | Series B | $150M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Pavilion Capital | — | Series B |